القيمة السوقية تغيير تاريخ
Acadia Pharmaceuticals USD 3.57B 100M 2026-11
Akebia Therapeutics USD 427M 297M 2025-12
ALKERMES USD 7.43B 629M 2026-11
Alnylam Pharmaceuticals USD 33.02B 7.17B 2026-09
Amarin USD 290M 51M 2025-12
ANI Pharmaceuticals USD 1.46B 206M 2026-11
BioMarin Pharmaceutical USD 10.68B 936M 2026-11
Coherus Biosciences USD 172M 19M 2025-12
Emergent BioSolutions USD 125M 51M 2023-12
Exelixis USD 19.82B 5.34B 2026-11
Glaxosmithkline GBP 101.7B 4.58B 2026-11
Heron Therapeutics USD 238M 7M 2025-12
Ionis Pharmaceuticals USD 4.24B 3.18B 2026-11
Lexicon Pharmaceuticals USD 418M 73M 2025-12
Lonza CHF 39.68B 980.61M 2025-06
Merck USD 375.59B 17.09B 2026-11
Moderna USD 99.14B 22.26B 2026-11
Nektar Therapeutics USD 2.12B 1.26B 2026-03
Neurocrine Biosciences USD 16.38B 1.96B 2026-11
Pacira USD 1.7B 696M 2026-11
Pfizer USD 165.12B 1.71B 2026-11
Sanofi EUR 100.56B 13.53B 2026-11
Sarepta Therapeutics USD 1.65B 276M 2026-11
United Therapeutics USD 28.64B 5.4B 2026-11
Vanda Pharmaceuticals USD 279M 6M 2024-12